Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$8,215,167
-$100,926 QoQ
Shares Held
32,347
-4.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#1,223
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Analysts, LLC holds $29,659,281 across 14 Drug Manufacturers - General names. JNJ ranks #2 (27.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
72,378 | $9,300,573 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
32,347 | $8,215,167 | |
| 3 | LLY |
ELI LILLY & Co
|
5,315 | $6,374,970 | |
| 4 | ABBV |
AbbVie Inc.
|
7,055 | $1,775,319 | |
| 5 | AMGN |
Amgen Inc
|
3,021 | $1,093,963 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,923 | $874,651 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
11,930 | $687,405 | |
| 8 | NVS |
Novartis AG
|
4,070 | $637,849 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,215,167 | 32,347 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $8,316,093 | 34,021 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $7,816,708 | 37,771 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $7,243,060 | 39,063 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,284,745 | 41,144 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $7,344,057 | 44,284 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,222,564 | 43,027 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,878,960 | 42,447 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $5,886,739 | 40,276 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,222,245 | 39,334 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,101,574 | 38,928 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $5,976,282 | 38,371 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,353,318 | 38,384 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,918,365 | 38,183 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $5,902,582 | 33,414 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $5,435,477 | 33,273 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,291,749 | 29,811 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,245,830 | 29,599 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $5,001,230 | 29,235 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $4,781,207 | 29,605 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $4,818,974 | 29,252 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $4,906,997 | 29,857 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,769,565 | 23,952 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,548,108 | 23,832 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,410,980 | 24,255 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $3,239,042 | 24,701 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||